{"id":"NCT02349295","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12-31","primaryCompletion":"2016-09-09","completion":"2019-06-26","firstPosted":"2015-01-28","resultsPosted":"2017-12-14","lastUpdate":"2020-07-01"},"enrollment":363,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriatic Arthritis"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Ixekizumab 80 mg Q4W","otherNames":["LY2439821"]},{"type":"DRUG","name":"Ixekizumab 80 mg Q2W","otherNames":["LY2439821"]}],"arms":[{"label":"Ixekizumab 80 milligram (mg) every 2 Weeks (Q2W)","type":"EXPERIMENTAL"},{"label":"Ixekizumab 80 mg Q4W","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The main purpose of this study is to evaluate how effective and safe the study drug known as ixekizumab is in participants with active psoriatic arthritis.","primaryOutcome":{"measure":"Percentage of Participants Achieving American College of Rheumatology 20 Index (ACR20)","timeFrame":"Week 24","effectByArm":[{"arm":"Placebo","deltaMin":19.5,"sd":null},{"arm":"Ixekizumab 80 mg Q4W","deltaMin":53.3,"sd":null},{"arm":"Ixekizumab 80 mg Q2W","deltaMin":48,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":8},"locations":{"siteCount":109,"countries":["United States","Australia","Czechia","France","Germany","Italy","Poland","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["40014255","38955921","38814433","37400681","35397092","35393269","33499913","33278016","32792421","31964419","31154634","30886974","30696483","30053162","28551073"],"seeAlso":["http://www.lillytrialguide.com/EN-us/studies/arthritis/rhbe"]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":123},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Sinusitis","Injection site reaction","Urinary tract infection"]}}